Ex parte BRUNSVELD et al. - Page 12




          Appeal No. 1997-1018                                                        
          Application No. 08/369,944                                                  


               Appellants argue that the data from the specification                  
          shows the “important relationship” between the MVTR and the                 
          hydroxyethyl acrylate content (Brief, page 3, citing Tables I,              
          II and III on page 14 of the specification).  Therefore, we                 
          reevaluate the evidence of prima facie obviousness in view of               
          the countervailing evidence of nonobviousness.  However,                    
          appellants’ evidence is not persuasive of nonobviousness since              
          there is no comparison with the closest prior art (i.e., the                
          12% hydroxyethyl methacrylate of Salve).  In re Burckel, 592                
          F.2d 1175, 1179,                                                            
          201 USPQ 67, 71 (CCPA 1979).  Furthermore, the comparison is                
          not commensurate with or predictive of the scope of the                     
          claimed subject matter.  In re Boesch, 617 F.2d 272, 277, 205               
          USPQ 215, 220 (CCPA 1980).  The comparison involves specific                
          monomers at certain concentrations while the claims are not so              
          limited.  Finally, the amount of the hydroxyethyl acrylate is               
          not the only variable in the comparison and thus the cause and              
          effect sought to be shown is lost.  In re Dunn, 349 F.2d 433,               
          439, 146 USPQ 479, 483 (CCPA 1965).  The comparison involves                
          adhesive coatings of different thicknesses.  As noted by                    


                                         12                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007